scholarly journals Stem‐cell mobilization of healthy sibling donors with pegfilgrastim—A prospective open‐label phase II trial ( EudraCT no: 2005‐004971‐39)

Transfusion ◽  
2021 ◽  
Author(s):  
Vladan Vucinic ◽  
Madlen Jentzsch ◽  
Sabine Leiblein ◽  
Enrica Bach ◽  
Yvonne Remane ◽  
...  
Keyword(s):  
Stem Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Stem Cell Mobilization ◽  
Open Label ◽  
Healthy Sibling ◽  
Open Label Phase ◽  
Cell Mobilization

Efficacy of rituximab and cladribine in patients with chronic lymphocytic leukemia and feasibility of stem cell mobilization: a prospective multicenter phase II trial (protocol SAKK 34/02)

2010 ◽  
Vol 51 (4) ◽  
pp. 613-619 ◽  
Author(s):  
Nicolas Leupin ◽  
Jan C. Schuller ◽  
Max Solenthaler ◽  
Dominik Heim ◽  
Alicia Rovo ◽  
...  
Keyword(s):  
Stem Cell ◽  
Chronic Lymphocytic Leukemia ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Lymphocytic Leukemia ◽  
Stem Cell Mobilization ◽  
Trial Protocol ◽  
Multicenter Phase ◽  
Cell Mobilization

scholarly journals A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer

2001 ◽  
Vol 27 (7) ◽  
pp. 677-681 ◽  
Author(s):  
GG Laport ◽  
GF Fleming ◽  
S Waggoner ◽  
TM Zimmerman ◽  
DL Grinblatt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Ovarian Cancer ◽  
Stem Cell ◽  
Phase Ii ◽  
Peripheral Blood ◽  
Peripheral Blood Stem Cell ◽  
Phase Ii Trial ◽  
Blood Stem Cell ◽  
Stem Cell Mobilization ◽  
Cell Mobilization

A554 Impaired Stem Cell Mobilization by Fludarabine in MM: Results from a Randomized Phase II Trial

2009 ◽  
Vol 9 ◽  
pp. S85
Author(s):  
HE Johnsen ◽  
S Lennhoff ◽  
Tangen ◽  
C Gluud ◽  
LM Knudsen ◽  
...  
Keyword(s):  
Stem Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Stem Cell Mobilization ◽  
Randomized Phase Ii ◽  
Cell Mobilization

scholarly journals Autologous Stem Cell Mobilization with Tbo-Filgrastim is Equvalent to Filgrastim: Results From a Randomized Phase II Trial

2017 ◽  
Vol 23 (3) ◽  
pp. S134
Author(s):  
Mark A. Fiala ◽  
Ravi Vij ◽  
Amanda Cashen ◽  
Keith Stockerl-Goldstein ◽  
John F. DiPersio ◽  
...  
Keyword(s):  
Stem Cell ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Stem Cell Mobilization ◽  
Randomized Phase Ii ◽  
Cell Mobilization

Bendamustine, Followed by Ofatumumab and Ibrutinib in Chronic Lymphocytic Leukaemia (CLL2-BIO): Primary Endpoint Analysis of a Multicentre, Open-Label Phase-II Trial

2019 ◽  
Author(s):  
Paula Cramer ◽  
Julia V. Tresckow ◽  
Sandra Robrecht ◽  
Jasmin Bahlo ◽  
Moritz Fürstenau ◽  
...  
Keyword(s):  
Chronic Lymphocytic Leukaemia ◽  
Phase Ii ◽  
Primary Endpoint ◽  
Lymphocytic Leukaemia ◽  
Phase Ii Trial ◽  
Open Label ◽  
Open Label Phase

Switch Maintenance Gemcitabine after First Line Chemotherapy in Patients with Malignant Mesothelioma: A Randomized Open Label Phase II Trial (NVALT19)

2020 ◽  
Author(s):  
Cornedine J. de Gooijer ◽  
Vincent van der Noort ◽  
Jos A. Stigt ◽  
Paul Baas ◽  
Bonne Biesma ◽  
...  
Keyword(s):  
Phase Ii ◽  
Malignant Mesothelioma ◽  
Phase Ii Trial ◽  
First Line ◽  
Open Label ◽  
Open Label Phase ◽  
Line Chemotherapy

A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancer

2014 ◽  
Vol 50 (18) ◽  
pp. 3136-3144 ◽  
Author(s):  
Tamas Hickish ◽  
Jim Cassidy ◽  
David Propper ◽  
Ian Chau ◽  
Stephen Falk ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Open Label ◽  
Open Label Phase

scholarly journals Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial

2019 ◽  
Vol 10 (25) ◽  
pp. 6185-6190
Author(s):  
Seung Tae Kim ◽  
Sung Yong Oh ◽  
Jeeyun Lee ◽  
Jung Hun Kang ◽  
Hyun Woo Lee ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Second Line ◽  
Open Label ◽  
Second Line Therapy ◽  
Biliary Tract Cancers ◽  
Line Therapy ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document